Ligand Pharmaceuticals Inc (LGND)

Free Cash Flow

$23.99M

Quarterly · Period ending: · USD

LGND logo

LGND Free Cash Flow

Latest reported$23.99M
LGND Quarterly Free Cash Flow (-$3.00M → $23.99M)
High-resolution chart · PNG

LGND free cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Free Cash Flow — Quarterly (USD)
Period endingFree Cash Flow (USD)
23,992,000
48,463,000
45,835,000
13,075,000
15,583,000
-25,730,000
27,759,000
22,289,000
11,175,000
18,586,000
6,699,000
7,159,000
-285,000
31,534,000
51,341,000
15,200,000
5,290,000
47,136,000
25,447,000
18,253,000
15,583,000
7,350,000
-3,921,000
10,708,000
23,591,000
16,922,000
-9,892,000
-6,197,000
-61,058,000
45,258,000
21,685,000
27,082,000
73,644,000
59,761,000
29,374,000
27,629,000
10,274,000
19,137,000
19,204,000
16,337,000
-8,292,000
7,430,000
11,800,000
9,159,000
5,583,000
4,322,000
7,683,000
3,468,000
3,963,000
953,000
11,031,000
-564,000
3,245,000
2,041,000
-5,839,000
-1,282,000
-974,000
-388,000
7,055,000
-1,166,000
-8,045,000
906,000
75,000
-7,679,000
-3,601,000
-15,932,000
-1,274,000
-11,558,000
2,844,000
-24,335,000
6,152,000
-13,517,000
-4,160,000
-9,595,000
-8,858,000
-14,269,000
-29,605,000
-45,435,000
-84,260,000
-28,939,000
-6,931,000
-20,174,000
11,804,000
-27,388,000
-8,453,000
-3,194,000
27,279,000
-7,856,000
-12,705,000
-4,568,000
7,634,000
-3,407,000
3,249,000
-9,985,000
-9,843,000
-4,235,000
-12,559,000
-1,636,000
-3,914,000
-7,147,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.